β-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
2001

β-Catenin Mutations in Endometrial Tumors

Sample size: 199 publication Evidence: moderate

Author Information

Author(s): Saegusa M, Hashimura M, Yoshida T, Okayasu I

Primary Institution: Kitasato University School of Medicine

Hypothesis

The study investigates the role of aberrant β-catenin expression during endometrial tumorigenesis.

Conclusion

The findings suggest that β-catenin abnormalities may play an important role in the early stages of endometrial hyperplasia leading to carcinoma.

Supporting Evidence

  • Cell membrane β-catenin showed a decrease from normal to grade 3 carcinomas.
  • Nuclear accumulation was higher in atypical hyperplasias and lower grade tumors compared to simple/complex hyperplasias.
  • Mutations in the β-catenin gene were found in 22.9% of endometrial carcinomas and 12.5% of atypical hyperplasias.
  • Significant association was found between β-catenin mutation and low grade histological malignancy.

Takeaway

This study looked at how changes in a protein called β-catenin might be linked to early stages of endometrial cancer.

Methodology

The study involved immunohistochemistry and genetic analysis of endometrial carcinoma and hyperplasia samples.

Participant Demographics

The study included 199 cases of endometrial carcinomas, 37 cases of hyperplasias, and 141 normal endometrial samples.

Statistical Information

P-Value

P = 0.048

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1581

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication